We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IAC:NASDAQIAC Inc. Analysis

Data as of 2026-04-09 - not real-time

$40.44

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

IAC is trading above its short‑term moving average while still beneath the long‑term average, indicating a short‑term uptrend within a broader upward bias. The 14‑day RSI is comfortably above the neutral midpoint, suggesting bullish momentum without being overbought. The MACD line sits above its signal line, generating a positive histogram. The price is perched just above a clear support zone and below a nearby resistance, providing a modest upside cushion. The Fear & Greed index reads “Extreme Greed,” reflecting strong market appetite for risk‑on names like IAC.
Fundamentally, the stock trades at a price‑to‑book well below one and its discounted cash‑flow estimate is substantially higher than the market price, implying meaningful upside. However, revenue has contracted and profit margins are negative, though cash flow remains positive and the recent divestiture of Care.com should improve the balance sheet. The lack of dividend and a beta near the market suggest average price volatility. Overall, the technical picture is supportive, but the fundamentals require a turnaround to sustain long‑term growth.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and RSI indicating strong momentum
  • Price near support with clear upside to resistance
  • DCF valuation suggests meaningful upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to book and DCF
  • Strategic divestiture of Care.com improving balance sheet
  • Stable volume and average beta supporting price stability

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue contraction and negative profit margins
  • Need for operational turnaround to sustain growth
  • Absence of dividend and modest cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth-10.50%
Profit Margin-4.35%
P/E Ratio17.9
ROE-2.10%
ROA0.81%
Debt/Equity33.99
P/B Ratio0.7
Op. Cash Flow$61.3M
Free Cash Flow$334.5M
Industry P/E18.4

Technical Analysis

TrendBullish
RSI63.0
Support$36.94
Resistance$41.46
MA 20$38.89
MA 50$37.63
MA 200$36.82
MACDBullish
VolumeStable
Fear & Greed Index83.61

Valuation

Fair Value$49.88
Target Price$47.33
Upside/Downside17.05%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.02
Volatility25.96%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.